TO ALL F.D.A. MEDICAL DOCTORS: ACTINIUM-225:

REMOVE HALF OF ALL MEN'S PROSTATES, OVER AGE THIRTY, IN NERVE-SPARING, ROBOT-ASSISTED SURGERIES, THEN, BIOPSY THOSE, FOR POTENTIAL PROSTATE CANCER TREATMENTS WITH ACTINIUM-225.

GET THEIR COLON POLYS OUT TOO, FOR CANCER BIOPSIES.

ALSO, CHECK THEM FOR HPV-RELATED ANAL CANCERS:

https://www.usatoday.com/story/news/nation-now/2018/05/29/cure-myeloid-leukemia-found-nuclear-waste-container/652228002/

https://prostatecancerinfolink.net/2016/07/15/a-first-in-human-trial-of-actinium-225-psma-617/

http://www.isotop.ru/en/production/medical/426/483/

https://www.urotoday.com/journal/everyday-urology-oncology-insights/articles/98187-a-review-on-the-development-of-targeted-alpha-therapy-in-the-treatment-of-cancer-focusing-on-the-first-and-only-fda-approved-targeted-alpha-therapy-radium-223-in-the-treatment-of-metastatic-castration-resistant-prostate-cancer-mcrpc.html

https://www.sciencedaily.com/releases/2017/10/171003111051.htm

http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.6_suppl.344

https://www.health.harvard.edu/newsletter_article/Prostate_cancer_surgery_Is_nerve-sparing_safe

http://www.urology.uci.edu/prostate/Potency_info.html

http://www.drcatalona.com/quest/quest_winter2002_3.htm